Key result
Continuous subcutaneous infusion of furosemide in advanced heart failure avoided hospital admission in 93% (26/28) of episodes aimed at correcting fluid balance.
Why the study?
Does continuous subcutaneous infusion of furosemide prevent hospital admission and improve symptoms in patients with advanced chronic heart failure?
Population
32 patients with advanced chronic heart failure (CHF) undergoing 43 consecutive episodes of treatment
Design
Case_series
Follow-up
median 10.5 days (range 2-48)
Authors
Loading...
May reduce hospitalizations in advanced HF; hypothesis-generating and requires prospective trials before practice change.
Observational (n=32)
Does continuous subcutaneous infusion of furosemide prevent hospital admission and improve symptoms in patients with advanced chronic heart failure?
Continuous subcutaneous infusion of furosemide is an effective strategy for preventing hospital admissions and managing symptoms in patients with advanced heart failure in the community.
Zacharias et al. (2011) conducted an observational in Advanced chronic heart failure (n=32). Continuous subcutaneous infusion of furosemide was evaluated on Hospital admission avoidance. Continuous subcutaneous infusion of furosemide in advanced heart failure avoided hospital admission in 93% (26/28) of episodes aimed at correcting fluid balance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: